NeuroPace (NPCE) Profit After Tax (2020 - 2026)
NeuroPace's (NPCE) quarterly Profit After Tax came in at -$6.7 million in Q1 2026, down 1.52% year-on-year from -$6.8 million in Q1 2025, and down 145.11% quarter-over-quarter from -$2.7 million in Q4 2025.
NeuroPace (NPCE) Profit After Tax (2020 - 2026) Analysis & Trends
NeuroPace's Profit After Tax history runs 7 years deep, the most recent figure standing at -$6.7 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 1.52% year-over-year to -$6.7 million in Q1 2026; TTM through Mar 2026 was -$21.6 million, a 13.06% increase from a year earlier, with the FY2025 full-year figure at -$21.5 million, up 20.91% from the prior year.
- Profit After Tax fell to -$6.7 million in Q1 2026 per NPCE's latest filing, from -$2.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$2.7 million in Q4 2025 and bottomed at -$12.7 million in Q2 2022.
- The 5-year median for Profit After Tax is -$7.5 million (2024), against an average of -$7.9 million.
- Across the five-year window, Profit After Tax tumbled 49.4% in 2022 and soared 48.02% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$10.1 million in 2022, then surged by 38.52% to -$6.2 million in 2023, then gained by 15.32% to -$5.2 million in 2024, then surged by 48.02% to -$2.7 million in 2025, then plunged by 145.11% to -$6.7 million in 2026.
- Per Business Quant, the three latest NPCE Profit After Tax figures stand at -$6.7 million (Q1 2026), -$2.7 million (Q4 2025), and -$3.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -6.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.69 Mn |
| Dec 31, 2025 | -2.73 Mn |
| Sep 30, 2025 | -3.50 Mn |
| Jun 30, 2025 | -8.65 Mn |
| Mar 31, 2025 | -6.59 Mn |
| Dec 31, 2024 | -5.25 Mn |
| Sep 30, 2024 | -5.45 Mn |
| Jun 30, 2024 | -7.51 Mn |
| Mar 31, 2024 | -8.93 Mn |
| Dec 31, 2023 | -6.20 Mn |
| Sep 30, 2023 | -7.26 Mn |
| Jun 30, 2023 | -9.12 Mn |
| Mar 31, 2023 | -10.38 Mn |
| Dec 31, 2022 | -10.08 Mn |
| Sep 30, 2022 | -11.67 Mn |
| Jun 30, 2022 | -12.69 Mn |
| Mar 31, 2022 | -11.46 Mn |
| Dec 31, 2021 | -10.69 Mn |
| Sep 30, 2021 | -8.06 Mn |
| Jun 30, 2021 | -8.49 Mn |